Journals / Anatolian Current Medical Journal / 2021 / Cilt: 3 - Sayı: 1

Evaluation of factors which determining survival of SARS COV-2 infected patients in intensive care unit

Pages
36–43
Publication Date
2021-01-22
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As the most determining factors, not being intubated during admission and / or follow-up was observed to be effective on survival and was found to be associated with mortality.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The disease SARS-CoV-2, which started in Wuhan city of China and caused pandemic, created an increasing number of intensive care needs due to its severe respiratory failure.
📊
Key Findings & Data:Methods: This study is a single-center retrospective study involving 156 patients admitted to our Intensive Care Unit , who was diagnosed with SARS-COV-2 between 20 March and 8 June 2020.
💡
Conclusion & Impact:As the most determining factors, not being intubated during admission and / or follow-up was observed to be effective on survival and was found to be associated with mortality.
🔬Design:Research Article
📍Scope:2020 Verileri
⚙️Variables:SARS-COV-2 · mortality · intubation

Abstract

Background: The disease SARS-CoV-2, which started in Wuhan city of China and caused pandemic, created an increasing number of intensive care needs due to its severe respiratory failure. The factors that determine the course of patients followed in intensive care are different. Therefore, our aim was to determine the factors that predict mortality and affect prognosis by evaluating the patients admitted to our intensive care unit. Methods: This study is a single-center retrospective study involving 156 patients admitted to our Intensive Care Unit , who was diagnosed with SARS-COV-2 between 20 March and 8 June 2020. The data including characteristics, symptoms and laboratory findings of the patients were recorded and their relationships to mortality were evaluated Results: The mean age was 69 ± 15 years and 63% were male. The most common symptom was dyspnea (69.9%) and fever (60,9 %), respectively. Comorbidity was present in 82% and the most common comorbidity was HT and DM, respectively. All patients were admitted to the intensive care unit with (due to) hypoxemic respiratory failure. 106 patients (68.8%) were connected to mechanical ventilation, which was associated with mortality (p <0.0001). High flow oxygen therapy was delivered in 31 patients and was associated with survival (p <0.05). Tozulizumab, given in addition to the treatments increased the survival (p<0.05). Conclusion: We saw in our study that many parameters will be effective in predicting survival. As the most determining factors, not being intubated during admission and / or follow-up was observed to be effective on survival and was found to be associated with mortality.

🔖

Cite This Article

İŞCANLI, İ. G. E., ŞAYLAN, B. (2021). Evaluation of factors which determining survival of SARS COV-2 infected patients in intensive care unit. Anatolian Current Medical Journal, Cilt: 3 - Sayı: 1, 36–43. https://ajindex.com/articles/733857

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Grennan D. What is a pandemic? JAMA 2019; 321: 910. doi: 10.1001/jama.2019.0700. World Health Organization. General’s opening remarks at the media briefing on COVID-19. Available at: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at- themedia-briefing-on-covid- Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-COV-2[J]. Nat Microbiol 2020; 5: 536–44. World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Available at: https://www.who.int/dg/speeches/detail/whodirector-general-s- remarks-at-the-media-briefing-on World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report-51 https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10 (Accessed on 06 June, 2020) Middle East Respiratory Syndrome Coronavirus. Available at: https://www.who.int/emergencies/mers-cov/en/. Accessed 06 June 2020 World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003.] Availablefromhttps://www.who.int/csr/sars/country/table2004_04_21/en/. Johns Hopkins University the Center for Systems Science and Engineering (JHU-CSSE) Coronavirus Resource Center https://coronavirus.jhu.edu/data/mortality Accessed 06 June 2020. The Republic of Turkey Ministry of Health General Directorate of Public Health. Accessed 24 JUNE 2020. Available from:https://hsgm.saglik.gov.tr/tr/covid19
  2. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323: 1061-9. doi:10.1001/jama.2020.1585 Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708-20. doi:10.1056/NEJMoa2002032 Norman G. Likert scales, levels of measurement and the "laws" of statistics. Adv Health Sci Educ Theory Pract 2010; 15: 625-32.
  3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239-42.
  4. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, Chi